TY - JOUR
T1 - Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes
AU - Penn Medicine BioBank
AU - PsycheMERGE Substance Use Disorder Workgroup
AU - Million Veteran Program
AU - Toikumo, Sylvanus
AU - Jennings, Mariela V.
AU - Pham, Benjamin K.
AU - Lee, Hyunjoon
AU - Mallard, Travis T.
AU - Bianchi, Sevim B.
AU - Meredith, John J.
AU - Vilar-Ribó, Laura
AU - Xu, Heng
AU - Hatoum, Alexander S.
AU - Johnson, Emma C.
AU - Pazdernik, Vanessa K.
AU - Jinwala, Zeal
AU - Pakala, Shreya R.
AU - Leger, Brittany S.
AU - Niarchou, Maria
AU - Ehinmowo, Michael
AU - Jenkins, Greg D.
AU - Batzler, Anthony
AU - Pendegraft, Richard
AU - Palmer, Abraham A.
AU - Zhou, Hang
AU - Biernacka, Joanna M.
AU - Coombes, Brandon J.
AU - Gelernter, Joel
AU - Xu, Ke
AU - Hancock, Dana B.
AU - Cox, Nancy J.
AU - Smoller, Jordan W.
AU - Davis, Lea K.
AU - Justice, Amy C.
AU - Kranzler, Henry R.
AU - Kember, Rachel L.
AU - Sanchez-Roige, Sandra
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature Limited 2024.
PY - 2024/6
Y1 - 2024/6
N2 - Tobacco use disorder (TUD) is the most prevalent substance use disorder in the world. Genetic factors influence smoking behaviours and although strides have been made using genome-wide association studies to identify risk variants, most variants identified have been for nicotine consumption, rather than TUD. Here we leveraged four US biobanks to perform a multi-ancestral meta-analysis of TUD (derived via electronic health records) in 653,790 individuals (495,005 European, 114,420 African American and 44,365 Latin American) and data from UK Biobank (ncombined = 898,680). We identified 88 independent risk loci; integration with functional genomic tools uncovered 461 potential risk genes, primarily expressed in the brain. TUD was genetically correlated with smoking and psychiatric traits from traditionally ascertained cohorts, externalizing behaviours in children and hundreds of medical outcomes, including HIV infection, heart disease and pain. This work furthers our biological understanding of TUD and establishes electronic health records as a source of phenotypic information for studying the genetics of TUD.
AB - Tobacco use disorder (TUD) is the most prevalent substance use disorder in the world. Genetic factors influence smoking behaviours and although strides have been made using genome-wide association studies to identify risk variants, most variants identified have been for nicotine consumption, rather than TUD. Here we leveraged four US biobanks to perform a multi-ancestral meta-analysis of TUD (derived via electronic health records) in 653,790 individuals (495,005 European, 114,420 African American and 44,365 Latin American) and data from UK Biobank (ncombined = 898,680). We identified 88 independent risk loci; integration with functional genomic tools uncovered 461 potential risk genes, primarily expressed in the brain. TUD was genetically correlated with smoking and psychiatric traits from traditionally ascertained cohorts, externalizing behaviours in children and hundreds of medical outcomes, including HIV infection, heart disease and pain. This work furthers our biological understanding of TUD and establishes electronic health records as a source of phenotypic information for studying the genetics of TUD.
UR - http://www.scopus.com/inward/record.url?scp=85190708348&partnerID=8YFLogxK
U2 - 10.1038/s41562-024-01851-6
DO - 10.1038/s41562-024-01851-6
M3 - Article
C2 - 38632388
AN - SCOPUS:85190708348
SN - 2397-3374
VL - 8
SP - 1177
EP - 1193
JO - Nature Human Behaviour
JF - Nature Human Behaviour
IS - 6
ER -